-
公开(公告)号:US08633314B2
公开(公告)日:2014-01-21
申请号:US13404137
申请日:2012-02-24
Applicant: Stephen Bierlmaier , Michael Christie , R. Scott Field , R. Curtis Haltiwanger , Linli He , Martin J. Jacobs , Michael Kress , Robert E. McKean , Dale R. Mowrey , Joseph Petraitis , Mehran Yazdanian , Veronique Courvoisier
Inventor: Stephen Bierlmaier , Michael Christie , Laurent Courvoisier , R. Scott Field , R. Curtis Haltiwanger , Linli He , Martin J. Jacobs , Michael Kress , Robert E. McKean , Dale R. Mowrey , Joseph Petraitis , Mehran Yazdanian
IPC: C07D295/12
CPC classification number: C07D487/04
Abstract: The present invention provides alternative forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
Abstract translation: 本发明提供了替代形式的化合物I,可重复制备它们的方法和使用它们治疗患者的方法。
-
公开(公告)号:US20120214998A1
公开(公告)日:2012-08-23
申请号:US13404137
申请日:2012-02-24
Applicant: Stephen Bierlmaier , Michael Christie , Laurent Courvoisier , Veronique Courvoisier , R. Scott Field , R. Curtis Haltiwanger , Linli He , Martin J. Jacobs , Michael Kress , Robert E. McKean , Dale R. Mowrey , Joseph Petraitis , Mehran Yazdanian
Inventor: Stephen Bierlmaier , Michael Christie , Laurent Courvoisier , Veronique Courvoisier , R. Scott Field , R. Curtis Haltiwanger , Linli He , Martin J. Jacobs , Michael Kress , Robert E. McKean , Dale R. Mowrey , Joseph Petraitis , Mehran Yazdanian
IPC: C07D295/12
CPC classification number: C07D487/04
Abstract: The present invention provides alternative forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
Abstract translation: 本发明提供了替代形式的化合物I,可重复制备它们的方法和使用它们治疗患者的方法。
-
公开(公告)号:US08513272B2
公开(公告)日:2013-08-20
申请号:US13105457
申请日:2011-05-11
Applicant: Stephen Bierlmaier , Raymond Scott Field , R. Curtis Haltiwanger , Martin J. Jacobs , Robert E. McKean , Mehran Yazdanian , Veronique Courvoisier
Inventor: Stephen Bierlmaier , Laurent Courvoisier , Raymond Scott Field , R. Curtis Haltiwanger , Martin J. Jacobs , Robert E. McKean , Mehran Yazdanian
IPC: A61K31/505 , C07D401/14
CPC classification number: C07D487/14
Abstract: Alternative chemical and/or solid state forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
Abstract translation: 化合物I的替代化学和/或固体形式,可重复地制备它们的方法和使用它们治疗患者的方法。
-
公开(公告)号:US20110230508A1
公开(公告)日:2011-09-22
申请号:US13105457
申请日:2011-05-11
Applicant: Stephen Bierlmaier , Laurent Courvoisier , Raymond Scott Field , R. Curtis Haltiwanger , Martin J. Jacobs , Robert E. McKean , Mehran Yazdanian , Veronique Courvoisier
Inventor: Stephen Bierlmaier , Laurent Courvoisier , Raymond Scott Field , R. Curtis Haltiwanger , Martin J. Jacobs , Robert E. McKean , Mehran Yazdanian , Veronique Courvoisier
IPC: A61K31/506 , C07D487/14 , A61P9/00 , A61P35/00
CPC classification number: C07D487/14
Abstract: Alternative chemical and/or solid state forms of Compound I, processes to reproducibly make them and methods of treating patients using them.
Abstract translation: 化合物I的替代化学和/或固体形式,可重复地制备它们的方法和使用它们治疗患者的方法。
-
公开(公告)号:US20090227650A1
公开(公告)日:2009-09-10
申请号:US12355284
申请日:2009-01-16
Applicant: Stephen Bierlmaier , Laurent Courvoisier , Raymond Scott Field , R.Curtis Haltiwanger , Martin J. Jacobs , Robert E. McKean , Mehran Yazdanian
Inventor: Stephen Bierlmaier , Laurent Courvoisier , Raymond Scott Field , R.Curtis Haltiwanger , Martin J. Jacobs , Robert E. McKean , Mehran Yazdanian
IPC: A61K31/407 , C07D245/04 , A61P35/02
CPC classification number: C07D498/08
Abstract: Novel crystalline forms of lestaurtinib are described, including six co-crystal forms, nineteen solvate forms, three anhydrate forms and one hemihydrate form. Methods of their preparation and use are also described.
Abstract translation: 描述了新颖的柳叶刀的结晶形式,包括六种共晶形式,十九种溶剂合物形式,三种无水形式和一种半水合物形式。 还描述了它们的制备和使用方法。
-
公开(公告)号:US6093553A
公开(公告)日:2000-07-25
申请号:US200063
申请日:1998-11-25
Applicant: Mehran Yazdanian , Barbara J. Bormann
Inventor: Mehran Yazdanian , Barbara J. Bormann
IPC: C12N15/09 , C07K14/025 , C12N5/10 , C12Q1/02 , C12R1/91 , C12Q1/08 , C07H21/04 , C12N5/00 , C12P21/06 , C12Q1/68
CPC classification number: C07K14/005 , C12N2710/22022
Abstract: A brain microvessel endothelial cell having a Middle-T antigen gene from papovirus is disclosed. The brain microvessel endothelial cell exhibits normal cell phenotype, maintains the phenotype in culture and forms monolayers substantially impermeable to low molecular weight molecules. The cells are useful for in vitro studies involving the blood brain barrier. Also disclosed, are methods of using and processes of making these cells.
Abstract translation: 公开了一种具有来自乳突病毒的中T抗原基因的脑微血管内皮细胞。 脑微血管内皮细胞表现出正常的细胞表型,维持培养中的表型,并形成对低分子量分子基本上不可渗透的单层。 细胞可用于涉及血脑屏障的体外研究。 还公开了使用和制造这些电池的方法。
-
公开(公告)号:US09796673B2
公开(公告)日:2017-10-24
申请号:US14975248
申请日:2015-12-18
Applicant: Raeann Wu , Ralph Curtis Haltiwanger , Stephen Bierlmaier , Mehran Yazdanian
Inventor: Raeann Wu , Ralph Curtis Haltiwanger , Stephen Bierlmaier , Mehran Yazdanian
IPC: C07D211/24 , C07C59/255 , C07C51/41
CPC classification number: C07D211/24 , C07C51/412 , C07C59/255
Abstract: The subject invention provides pridopidine L-tartrate, compositions and a process for manufacture thereof.
-
公开(公告)号:US20160176821A1
公开(公告)日:2016-06-23
申请号:US14975248
申请日:2015-12-18
Applicant: Raeann Wu , Ralph Curtis Haltiwanger , Stephen Bierlmaier , Mehran Yazdanian
Inventor: Raeann Wu , Ralph Curtis Haltiwanger , Stephen Bierlmaier , Mehran Yazdanian
IPC: C07D211/24 , C07C51/41 , C07C59/255
CPC classification number: C07D211/24 , C07C51/412 , C07C59/255
Abstract: The subject invention provides pridopidine L-tartrate, compositions and a process for manufacture thereof.
Abstract translation: 本发明提供了酒石酸布里凡定,组合物及其制备方法。
-
9.
公开(公告)号:US20050148555A1
公开(公告)日:2005-07-07
申请号:US10921448
申请日:2004-08-19
Applicant: Abhya Gupta , Philippe Iacono , Linda Kelash-Cannavo , Jeffrey Madwed , Jung-Yong Park , Susan Way , Mehran Yazdanian
Inventor: Abhya Gupta , Philippe Iacono , Linda Kelash-Cannavo , Jeffrey Madwed , Jung-Yong Park , Susan Way , Mehran Yazdanian
IPC: A61K31/192 , A61K31/415 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/5375 , A61K31/5377 , A61K31/557 , A61K31/573 , A61K31/58 , A61K31/60 , A61K45/06
CPC classification number: A61K45/06 , A61K31/505 , A61K31/506 , A61K31/5375 , A61K31/5377
Abstract: Disclosed are methods of treating COPD and Pulmonary Hypertension using p38 Map Kinase inhibitors in combination with one or more other active ingredients.
Abstract translation: 公开了使用p38 Map Kinase抑制剂与一种或多种其它活性成分组合治疗COPD和肺高血压的方法。
-
-
-
-
-
-
-
-